Atomoxetine Hydrochloride Drug Interactions: 27 Major
Atomoxetine Hydrochloride Drug Interactions
Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Atomoxetine Hydrochloride. Always confirm against the full prescribing information.
100 interactions
Abacavir
Atomoxetine may increase the hepatotoxic activities of Abacavir.
Level 2 evidence
Abatacept
The metabolism of Atomoxetine can be increased when combined with Abatacept.
Level 1 evidence
Abiraterone
The metabolism of Atomoxetine can be decreased when combined with Abiraterone.
Level 1 evidence
Acarbose
Acarbose may increase the hepatotoxic activities of Atomoxetine.
Level 2 evidence
Acebutolol
The metabolism of Atomoxetine can be decreased when combined with Acebutolol.
Level 1 evidence
Acetaminophen
Atomoxetine may increase the hepatotoxic activities of Acetaminophen.
Level 2 evidence
Acetazolamide
Atomoxetine may increase the hepatotoxic activities of Acetazolamide.
Level 2 evidence
Acitretin
Atomoxetine may increase the hepatotoxic activities of Acitretin.
Level 2 evidence
Adalimumab
The metabolism of Atomoxetine can be increased when combined with Adalimumab.
Level 1 evidence
Albendazole
Atomoxetine may increase the hepatotoxic activities of Albendazole.
Level 2 evidence
Albuterol
Atomoxetine may increase the tachycardic activities of Salbutamol.
Level 1 evidence
Allopurinol
Atomoxetine may increase the hepatotoxic activities of Allopurinol.
Level 2 evidence
Enter your NPI to unlock 2 major interactions for Atomoxetine Hydrochloride
Atomoxetine Hydrochloride has 1058 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Atomoxetine Hydrochloride has 27 major, 333 moderate, and 698 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Atomoxetine Hydrochloride. Always confirm against the full prescribing information.